COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination-Reference-Cited by-同舟云学术

COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination

Published:2021-12-22 Issue:3 Volume:9 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Srivastava Kshitij¹,West Kamille A.¹,De Giorgi Valeria¹,Holbrook Michael R.²,Bovin Nicolai V.³⁴,Henry Stephen M.⁴,Flegel Willy A.¹^ORCID

Affiliation:

1. Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA

2. National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility, National Institutes of Health, Frederick, Maryland, USA

3. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia

4. Centre for Kode Technology Innovation, School of Engineering, Computer and Mathematical Sciences, Faculty of Design and Creative Technologies, Auckland University of Technology, Auckland, New Zealand

Abstract

We recently developed a red cell based assay to detect SARS-CoV-2 antibodies in human plasma. In the current study, we show the hands-on application of this assay in a group of COVID-19 convalescent plasma donors and healthy individuals.

Funder

New Zealand Ministry of Business, Innovation & Employment

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

HHS | NIH | NIH Clinical Center

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/Spectrum.00830-21

Reference44 articles.

1. WHO coronavirus disease (COVID-19) dashboard. 2020. World Health Organization. https://covid19.who.int/. Accessed July 7 2021.

2. Reuters. 2020. CanSino's COVID-19 vaccine candidate approved for military use in China. https://www.reuters.com/article/us-health-coronavirus-china-vaccine/cansinos-covid-19-vaccine-candidate-approved-for-military-use-in-china-idUSKBN2400DZ. Accessed July 7 2021.

3. Ullah Z Rahim Z. 2020. Putin says Russia has approved 'world first' Covid-19 vaccine. But questions over its safety remain. https://www.cnn.com/2020/08/11/europe/russia-coronavirus-vaccine-putin-intl/index.html. Accessed July 7 2021.

4. FDA. 2021. Pfizer-BioNTech COVID-19 vaccine. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine. Accessed July 7 2021.

5. Craven J. 2021. COVID-19 vaccine tracker. https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker. Accessed July 7 2021.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel syphilis Treponema pallidum lipoprotein peptide antigen diagnostic assay using red cell kodecytes in routine blood centre column agglutination testing platforms;Vox Sanguinis;2024-06-30

2. Continuous population surveillance of COVID-19 immunity can be provided by Blood Services at low cost using routine laboratory infrastructure;BLOOD TRANSFUS-ITALY;2022

3. Simulated RBC antibody identification training panels created using SARS‐CoV ‐2 kodecytes and immune plasma;Transfusion;2022-07-11

4. Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time?;Vaccines;2022-03-08

5. Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals;eJHaem;2021-11-26